Patents by Inventor Tim Köhler
Tim Köhler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240152518Abstract: The disclosed technology is generally directed to graph queries with reduced latencies. In one example of the technology, there is a cross-tenancy collaboration between two different tenancies: a first tenancy that is homed in a first geographical region and a second tenancy that is homed in a second geographical region. In the first geographical region, a first set of graph data is stored. The first set of the graph data is associated with the first tenancy. A portion of the first set of the graph data to be copied from the first geographical region to the second geographical region is determined. In response to determining the portion of the first set of the graph data, a copy of the portion of the first set of the graph data is stored in the second geographical region.Type: ApplicationFiled: November 7, 2022Publication date: May 9, 2024Inventors: Åge Andre KVALNES, Kaare Koehler HOEVIK, Tim SCHMIDT, Nicholas John ELDER, Charitha Herath DASKON HERATH MUDIYANSELAGE
-
Patent number: 11945385Abstract: An energy absorption device for a bumper of a motor vehicle has a first deformation element on the front side of the bumper. The first deformation element is a foam shaped part which extends over the width of the bumper and has a density of from 20 to 50 g/l. At least one second deformation element, with a density which is at least 50 g/l higher than the first deformation element, is inserted into the first deformation element.Type: GrantFiled: March 2, 2020Date of Patent: April 2, 2024Assignee: Bayerische Motoren Werke AktiengesellschaftInventors: Martin Gross, Arne Koehler, Tamara Manske, Christian Muselmann, Mazdak Novine, Tim Rudolph, Manuel Schroeder
-
Publication number: 20200009375Abstract: A device for killing blood-borne pathogens, and a method of using this device to effectively remove blood-borne pathogens from the body of a human or animal is claimed. The device comprises a wire that is inserted into the blood stream of a patient, which releases metallic ions which effectively kill the pathogens. There are several embodiments, each of which has a combination of covered and uncovered portions of the wire. The wire is electrically connected to both a source of power and a Power Supply with PCB or controller/software, which controls the intensity and during of the treatment.Type: ApplicationFiled: May 14, 2019Publication date: January 9, 2020Inventor: Tim Koehler
-
Patent number: 9913789Abstract: The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.Type: GrantFiled: July 1, 2014Date of Patent: March 13, 2018Assignee: Evonik Degussa GmbHInventors: Tim Köhler, Mike Farwick, Matthias Mentel, Peter Lersch
-
Patent number: 9662515Abstract: The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyric acid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyric acid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.Type: GrantFiled: July 20, 2012Date of Patent: May 30, 2017Assignee: EVONIK DEGUSSA GMBHInventors: Tim Köhler, Jennifer Schild, Matthias Mentel, Peter Lersch, Mike Farwick, Christian Weitemeyer
-
Patent number: 9610232Abstract: The invention relates to the use of sphinganine for improving the visual appearance of skin and hair, for caring for, for protecting and/or for stimulating the growth of skin and hair.Type: GrantFiled: July 4, 2012Date of Patent: April 4, 2017Assignee: EVONIK DEGUSSA GMBHInventors: Mike Farwick, Tim Koehler, Matthias Mentel
-
Patent number: 9598711Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.Type: GrantFiled: June 27, 2016Date of Patent: March 21, 2017Assignee: EVONIK DEGUSSA GMBHInventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
-
Publication number: 20160304916Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.Type: ApplicationFiled: June 27, 2016Publication date: October 20, 2016Applicant: EVONIK DEGUSSA GMBHInventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
-
Patent number: 9404118Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.Type: GrantFiled: July 23, 2012Date of Patent: August 2, 2016Assignee: EVONIK DEGUSSA GMBHInventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
-
Patent number: 9388439Abstract: The invention relates to novel enzymes that provide acetylated sphingoid bases.Type: GrantFiled: March 13, 2013Date of Patent: July 12, 2016Assignee: EVONIK DEGUSSA GMBHInventors: Steffen Schaffer, Mike Farwick, Heiko Andrea, Tim Koehler, Daniel Wolff, Frank ter Veld, Ansgar Poetsch, Eckhard Boles, Christoph Schorsch
-
Publication number: 20160184204Abstract: The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.Type: ApplicationFiled: July 1, 2014Publication date: June 30, 2016Applicant: Evonik Degussa GmbHInventors: Tim KÖHLER, Mike FARWICK, Matthias MENTEL, Peter LERSCH
-
Publication number: 20150118721Abstract: The invention relates to novel enzymes that provide acetylated sphingoid bases.Type: ApplicationFiled: March 13, 2013Publication date: April 30, 2015Applicant: EVONIK INDUSTRIES AGInventors: Steffen Schaffer, Mike Farwick, Heiko Andrea, Tim Koehler, Daniel Wolff, Frank ter Veld, Ansgar Poetsch, Eckhard Boles, Christoph Schorsch
-
Patent number: 8980594Abstract: The invention relates to the use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase, a fusion protein comprising a 3-hydroxycarboxylic acid-CoA mutase and a protein sequence homologous to a MeaB protein and an enzymatic method for producing 2-hydroxyisobutryric acid.Type: GrantFiled: October 11, 2010Date of Patent: March 17, 2015Assignee: Evonik Roehm GmbHInventors: Liv Reinecke, Steffen Schaffer, Tim Koehler, Anja Thiessenhusen, Achim Marx, Markus Buchhaupt
-
Publication number: 20140308310Abstract: The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyricacid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyricacid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.Type: ApplicationFiled: July 20, 2012Publication date: October 16, 2014Applicant: EVONIK DEGUSSA GMBHInventors: Tim Köhler, Jennifer Schild, Matthias Mentel, Peter Lersch, Mike Farwick, Christian Weitemeyer
-
Publication number: 20140309309Abstract: The invention relates to a cosmetic formulation and to its use.Type: ApplicationFiled: October 23, 2012Publication date: October 16, 2014Applicant: EVONIK INDUSTRIES AGInventors: Mike Farwick, Matthias Mentel, Tim Köhler
-
Publication number: 20140199736Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.Type: ApplicationFiled: July 23, 2012Publication date: July 17, 2014Applicant: EVONIK DEGUSSA GMBHInventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
-
Publication number: 20140170092Abstract: The invention relates to the use of sphinganine for improving the visual appearance of skin and hair, for caring for, for protecting and/or for stimulating the growth of skin and hair.Type: ApplicationFiled: July 4, 2012Publication date: June 19, 2014Applicant: EVONIK DEGUSSA GMBHInventors: Mike Farwick, Tim Koehler, Matthias Mentel
-
Publication number: 20130315849Abstract: The invention relates to the use of 13-hydroxy-9,11-octadecadienoic acid for tanning human skin and methods associated therewith.Type: ApplicationFiled: December 12, 2011Publication date: November 28, 2013Applicant: EVONIK GOLDSCHMIDT GMBHInventors: Mike Farwick, Tim Koehler
-
Publication number: 20120264182Abstract: The invention relates to the use of a protein homologous to a MeaB protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-CoA mutase, a fusion protein comprising a 3-hydroxycarboxylic acid-CoA mutase and a protein sequence homologous to a MeaB protein and an enzymatic method for producing 2-hydroxyisobutryric acid.Type: ApplicationFiled: October 11, 2010Publication date: October 18, 2012Applicant: EVONIK ROEHM GMBHInventors: Liv Reinecke, Steffen Schaffer, Tim Koehler, Anja Thiessenhusen, Achim Marx, Markus Buchhaupt
-
Publication number: 20120244094Abstract: The invention relates to the use of the tetrapeptide PKEK for brightening human skin, for bleaching pigmented spots and/or for leveling out irregularities in skin coloration.Type: ApplicationFiled: October 18, 2010Publication date: September 27, 2012Applicant: EVONIK GOLDSCHMIDT GMBHInventors: Mike Farwick, Ursula Maczkiewitz, Tim Koehler